Eli Lilly has announced that its next-generation obesity drug has shown significant weight loss results in clinical trials, with patients losing up to 28% of their body weight. The drug has also been reported to have other benefits, including curbing sleep apnea. Some outlets have noted that weight loss of up to 85 pounds was observed, with the drug delivering results comparable to surgery in some cases.